Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I et al (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5(12):1749–1768

National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395–409

Article  Google Scholar 

Walter JE, Heuvelmans MA, de Jong PA, Vliegenthart R, van Ooijen PMA, Peters RB, Ten Haaf K, Yousaf-Khan U, van der Aalst CM, de Bock GH et al (2016) Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol 17(7):907–916

Article  Google Scholar 

de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, Lammers JJ, Weenink C, Yousaf-Khan U, Horeweg N et al (2020) Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 382(6):503–513

Article  Google Scholar 

Yamato Y, Tsuchida M, Watanabe T, Aoki T, Koizumi N, Umezu H, Hayashi J (2001) Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung. Ann Thorac Surg 71(3):971–974

Article  CAS  Google Scholar 

Chen T, Luo J, Wang R, Gu H, Gu Y, Huang Q, Wang Y, Zheng J, Yang Y, Zhao H (2018) Prognosis of limited resection versus lobectomy in elderly patients with invasive lung adenocarcinoma with tumor size less than or equal to 2 cm. J Thorac Dis 10(4):2231–2239

Article  Google Scholar 

Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, Park BJ, Rusch VW, Travis WD (2011) Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 24(5):653–664

Article  CAS  Google Scholar 

Cerfolio RJ, Bryant AS (2008) Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study. J Thorac Cardiovasc Surg 135(2):261–268

Article  Google Scholar 

Ellis MC, Hessman CJ, Weerasinghe R, Schipper PH, Vetto JT (2011) Comparison of pulmonary nodule detection rates between preoperative CT imaging and intraoperative lung palpation. Am J Surg 201(5):619–622

Article  Google Scholar 

Orosco RK, Tapia VJ, Califano JA, Clary B, Cohen EEW, Kane C, Lippman SM, Messer K, Molinolo A, Murphy JD et al (2018) Positive surgical margins in the 10 most common solid cancers. Sci Rep 8(1):5686

Article  Google Scholar 

Osarogiagbon RU, Lin CC, Smeltzer MP, Jemal A (2016) Prevalence, prognostic implications, and survival modulators of incompletely resected non-small cell lung cancer in the U.S. national cancer data base. J Thorac Oncol 11(1):e5-16

Article  Google Scholar 

Wind J, Smit EJ, Senan S, Eerenberg JP (2007) Residual disease at the bronchial stump after curative resection for lung cancer. Eur J Cardiothorac Surg 32(1):29–34

Article  Google Scholar 

Riquet M, Achour K, Foucault C, Le Pimpec BF, Dujon A, Cazes A (2010) Microscopic residual disease after resection for lung cancer: a multifaceted but poor factor of prognosis. Ann Thorac Surg 89(3):870–875

Article  Google Scholar 

al-Kattan K, Sepsas E, Fountain SW, Townsend ER (1997) Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg 12(3):380–4

Article  CAS  Google Scholar 

Roth K, Nilsen TI, Hatlen E, Sorensen KS, Hole T, Haaverstad R (2008) Predictors of long time survival after lung cancer surgery: a retrospective cohort study. BMC Pulm Med 8:22

Article  Google Scholar 

Uramoto H, Tanaka F (2014) Recurrence after surgery in patients with NSCLC. Transl Lung Cancer Res 3(4):242–249

Google Scholar 

Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde CJ, Frangioni JV (2013) Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol 10(9):507–518

Article  CAS  Google Scholar 

Frangioni JV (2008) New technologies for human cancer imaging. J Clin Oncol 26(24):4012–4021

Article  Google Scholar 

van Oosten M, Crane LM, Bart J, van Leeuwen FW, van Dam GM (2011) Selecting potential targetable biomarkers for imaging purposes in colorectal cancer using target selection criteria (TASC): a novel target identification tool. Transl Oncol 4(2):71–82

Article  Google Scholar 

Cancer Genome Atlas Research N (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489(7417):519–25

Article  Google Scholar 

Cancer Genome Atlas Research N (2014) Comprehensive molecular profiling of lung adenocarcinoma. Nature 511(7511):543–50

Article  Google Scholar 

Consortium GT (2013) The genotype-tissue expression (GTEx) project. Nat Genet 45(6):580–585

Article  Google Scholar 

Abrams ZB, Johnson TS, Huang K, Payne PRO, Coombes K (2019) A protocol to evaluate RNA sequencing normalization methods. BMC Bioinform 20(Suppl 24):679

Article  CAS  Google Scholar 

Bausch-Fluck D, Hofmann A, Bock T, Frei AP, Cerciello F, Jacobs A, Moest H, Omasits U, Gundry RL, Yoon C et al (2015) A mass spectrometric-derived cell surface protein atlas. PLoS One 10(3):e0121314

Article  Google Scholar 

Bausch-Fluck D, Goldmann U, Muller S, van Oostrum M, Muller M, Schubert OT, Wollscheid B (2018) The in silico human surfaceome. Proc Natl Acad Sci U S A 115(46):E10988–E10997

Article  CAS  Google Scholar 

Fonseca AL, da Silva VL, da Fonsêca MM, Meira IT, da Silva TE, Kroll JE, Ribeiro-Dos-Santos AM, Freitas CR, Furtado R, de Souza JE et al (2016) Bioinformatics analysis of the human surfaceome reveals new targets for a variety of tumor types. Int J Genomics 8346198

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47

Article  Google Scholar 

Zhang JZ, Ismail-Beigi F (1998) Activation of Glut1 glucose transporter in human erythrocytes. Arch Biochem Biophys 356(1):86–92

Article  CAS  Google Scholar 

Imrich S, Hachmeister M, Gires O (2012) EpCAM and its potential role in tumor-initiating cells. Cell Adh Migr 6(1):30–38

Article  Google Scholar 

Lonergan KM, Chari R, Coe BP, Wilson IM, Tsao MS, Ng RT, Macaulay C, Lam S, Lam WL (2010) Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE. PLoS ONE 5(2):e9162

Article  Google Scholar 

Zito Marino F, Bianco R, Accardo M, Ronchi A, Cozzolino I, Morgillo F, Rossi G, Franco R (2019) Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications. Int J Med Sci 16(7):981–989

Article  Google Scholar 

Carnio S, Novello S, Papotti M, Loiacono M, Scagliotti GV (2013) Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures. Transl Lung Cancer Res 2(5):372–381

CAS  Google Scholar 

Predina JD, Newton AD, Xia L, Corbett C, Connolly C, Shin M, Sulyok LF, Litzky L, Deshpande C, Nie S et al (2018) An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas. Oncotarget 9(17):13517–13529

Article  Google Scholar 

Predina JD, Newton AD, Keating J, Dunbar A, Connolly C, Baldassari M, Mizelle J, Xia L, Deshpande C, Kucharczuk J et al (2018) A phase I clinical trial of targeted intraoperative molecular imaging for pulmonary adenocarcinomas. Ann Thorac Surg 105(3):901–908

Article  Google Scholar 

O’Shannessy DJ, Yu G, Smale R, Fu YS, Singhal S, Thiel RP, Somers EB, Vachani A (2012) Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance. Oncotarget 3(4):414–425

Article  Google Scholar 

Cagle PT, Zhai QJ, Murphy L, Low PS (2013) Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents. Arch Pathol Lab Med 137(2):241–244

Article  CAS  Google Scholar 

Boogerd LS, van der Valk MJ, Boonstra MC, Prevoo HA, Hilling DE, van de Velde CJ, Sier CF, Fariña Sarasqueta A, Vahrmeijer AL (2018) Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy. Onco Targets Ther 11:1655–1664

Article  Google Scholar 

Li X, Xu K, Cen R, Deng J, Hao Z, Liu J, Takizawa H, Ng CSH, Marulli G, Kim MP et al (2021) Preoperative computer tomography-guided indocyanine green injection is associated with successful localization of small pulmonary nodules. Transl Lung Cancer Res 10(5):2229–2236

Article  CAS  Google Scholar 

Quan YH, Oh CH, Jung D, Lim JY, Choi BH, Rho J, Choi Y, Han KN, Kim BM, Kim C et al (2020) Evaluation of intraoperative near-infrared fluorescence visualization of the lung tumor margin with indocyanine green inhalation. JAMA Surg 155(8):732–740

Article  Google Scholar 

Huang C, Liang J, Lei X, Xu X, Xiao Z, Luo L (2019) Diagnostic performance of perfusion computed tomography for differentiating lung cancer from benign lesions: a meta-analysis. Med Sci Monit 25:3485–3494

Article  Google Scholar 

Bharadwaj S (n.d.) Evaluation of IRDye800CW-nimotuzumab in lung cancer surgery

Rosenthal E (n.d.) A Phase I/II study evaluating the safety and pharmacokinetics of panitumumab-IRDye800 as an optical imaging agent to detect lung cancer during surgical procedures

A Phase 2a, single-dose, open-label study to evaluate diagnostic performance, safety & timing of postdose imaging of ONM-100, an intraoperative fluorescence imaging agent for the detection of cancer, in patients with solid tumors undergoing routine surgery [Internet]. Available from: https://www.clinicaltrials.gov/ct2/show/record/NCT03735680

Intraoperative imaging of pulmonary nodules by SGM-101 [Internet]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT04315467

Intraoperative Molecular Imaging Of Pulmonary Nodules By SGM-101, A Fluorochrome-labeled anti-carcino-embryonic antigen (CEA) monoclonal antibody [Internet]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT04315467

Hekman MC, Rijpkema M, Muselaers CH, Oosterwijk E, Hulsbergen-Van de Kaa CA, Boerman OC, Oyen WJ, Langenhuijsen JF, Mulders PF (2018) Tumor-targeted dual-modality imaging to improve intraoperative visualization of clear cell renal cell carcinoma: a first in man study. Theranostics 8(8):2161–2170

Article  CAS  Google Scholar 

A phase I study assessing the safety and performance of VB5-845D-800CW, an anti-Epcam fluorescent agent, for the intraoperative detection of gastrointestinal cancer [Internet]. Available from: https://www.trialregister.nl/trial/7363